Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis. - Wikidata - awgldk - TriplyDB

Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis.

Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis.

http://www.wikidata.org/entity/Q41788599

about

The role of IL-10 in Mycobacterium avium subsp. paratuberculosis infection SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytes Allergic contact dermatitis in psoriasis patients: typical, delayed, and non-interacting.Inhibition of inflammatory and proliferative responses of human keratinocytes exposed to the sesquiterpene lactones dehydrocostuslactone and costunolide.CARD14 expression in dermal endothelial cells in psoriasis.SOCS1 suppresses IL-1β-induced C/EBPβ expression via transcriptional regulation in human chondrocytes.SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications.Toll-Like Receptor Pathways in Autoimmune Diseases.Phosphoinositide 3-Kinase-Dependent Signalling Pathways in Cutaneous Squamous Cell Carcinomas.Acitretin modulates HaCaT cells proliferation through STAT1- and STAT3-dependent signaling.Leishmania donovani prevents oxidative burst-mediated apoptosis of host macrophages through selective induction of suppressors of cytokine signaling (SOCS) proteins.Human metapneumovirus inhibits the IL-6-induced JAK/STAT3 signalling cascade in airway epithelium.First-in-human studies of seletalisib, an orally bioavailable small-molecule PI3Kδ inhibitor for the treatment of immune and inflammatory diseases.Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model Insights into gene expression profiles induced by Socs3 depletion in keratinocytes.Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis.IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment

P2860

Q28073482-EE817F92-A83A-4DFE-BBA8-6313909C853A Q33648604-1278F12D-BF99-4A43-AC35-FECFB1652B33 Q33945724-8064E60E-4652-4BEF-93C2-6CD22029CAB0 Q35255673-4A184431-8E5A-44D6-8576-285CDD64231A Q35392242-D5E0EAC4-CEDF-4834-8179-787CCA12819B Q37057703-8AD9D161-402B-4EDB-BA38-1F68224F0EC9 Q38193362-DF382B99-199D-45C0-9F21-1D4914C09B01 Q38357504-77F520EA-FAEA-4C2E-9B4C-DD42D965DE08 Q38684394-1175FA2F-66DC-4CEB-BB98-2FD543FF961E Q38701290-0C65C470-4FEB-4F1E-91EC-B2DB24C04FFB Q39055055-C63FC8D0-84C7-4CC8-B14C-7A55C5CD6721 Q39082160-41F4C816-3C2D-478E-8F93-50794DCBCAE0 Q41991078-A0994FF5-7B4E-4FD9-B43A-2969CF066F06 Q42369054-572ACB6C-67C5-48ED-AE91-446833451BC0 Q46602150-BB0C4834-4E37-4F12-93CA-23FB4B9E9523 Q48132042-4FCDD494-DF42-433B-9B16-B74E021250B6 Q58093804-0906E028-C803-40A7-A411-5EB9A4784AEA

P2860

Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis.

http://www.wikidata.org/entity/Q41788599

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis.

@en

type

label

Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis.

@en

prefLabel

Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis.

@en

P1433

Q41788599-A0513B36-11AD-41D2-8CD6-94991E1822D9

P1476

Q41788599-184802A0-D516-457C-91F4-48D0BA921F44

P2093

Q41788599-20377470-2FF3-45D8-BA86-1BD2C129A68A

Q41788599-5668C240-BDB9-4A6D-9617-D0644780A403

Q41788599-9CDB52E9-6D3E-4014-90C0-C5E6CE236767

Q41788599-B8756837-CCF0-4E4E-8E67-F670DA08CF9B

Q41788599-DC3D6200-AE45-4889-827D-24A2CB9662A7

P2860

Q41788599-05C6CC5D-1114-44BD-BFAB-72E14BAC0F01

Q41788599-066AFF30-B1DB-4BC8-B36C-82DBC7634BDA

Q41788599-113A9FBD-4C1E-41FA-A05E-B8A5C85C87BA

Q41788599-1D4231A7-EBBC-4B1E-8782-738500D06007

Q41788599-1DA7984D-61CF-492C-A4C7-40E8D1EB379C

Q41788599-1F1BBA51-0E1F-4193-8215-0B43A70A3059

Q41788599-1F9824FC-5625-4B50-AE13-1251E51483C6

Q41788599-2EAD1B98-B600-46B1-93CF-273C19D5E75F

Q41788599-45D0280E-BEE1-435D-A83D-97A889222559

Q41788599-474FE16D-CE53-4407-AD7C-AAA4A3D523E7

P2888

Q41788599-672688D2-ADF4-473A-AE1F-5B11A8E33581

P304

Q41788599-EC3DE958-F0DE-4F70-A6FE-92E9288AA0B0

P31

Q41788599-30A46DCC-6E09-4FC2-BFE7-5CFA45878CD6

P356

Q41788599-EB967489-E5EB-4AEF-B446-4F45D191BCA0

P478

Q41788599-48ACF7CD-902E-4A93-B874-2FE42137424E

P577

Q41788599-7F360D15-DEEC-4C9D-A227-1445FEA98530

P5875

Q41788599-16FE3E72-5283-4397-9F42-FEFCE6D43DD2

P6179

Q41788599-A6458BA6-0075-4677-A0E7-0AD13632F0C0

P698

Q41788599-2727D6DB-34C6-4C71-917C-A18A650D918C

P921

Q41788599-08302032-9A56-4D09-97A0-889CD5C20793

P932

Q41788599-21DAB71B-BB74-4134-AEE1-412BCFDE134D

P356

P1433

Cell Death and Disease

P1476

Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis.

@en

P2093

A Cavani

http://www.w3.org/2001/XMLSchema#string

C Albanesi

http://www.w3.org/2001/XMLSchema#string

C Scarponi

http://www.w3.org/2001/XMLSchema#string

S Madonna

http://www.w3.org/2001/XMLSchema#string

S Pallotta

http://www.w3.org/2001/XMLSchema#string

P2860

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling

Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1

Cell death in the skin.

New mimetic peptides of the kinase-inhibitory region (KIR) of SOCS1 through focused peptide libraries.

Suppressor of cytokine signaling 1 (SOCS1) limits NFkappaB signaling by decreasing p65 stability within the cell nucleus.

Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling.

IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3.

Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin.

P2888

P304

e334

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDDIS.2012.69

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228082120

http://www.w3.org/2001/XMLSchema#string

P6179

1011669818

http://www.w3.org/2001/XMLSchema#string

P698

22739986

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

3388239

http://www.w3.org/2001/XMLSchema#string